Alvotech (ALVO) Long-Term Debt Issuances (2022 - 2026)
Alvotech's (ALVO) quarterly Long-Term Debt Issuances came in at $13.5 million in Q1 2026, down 94.22% on a QoQ basis from $233.5 million in Q4 2025.
Alvotech (ALVO) Long-Term Debt Issuances (2022 - 2026) Analysis & Trends
Alvotech (ALVO) has 5 years of Long-Term Debt Issuances data on file, last reported at $13.5 million in Q1 2026.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (changed N/A YoY) and the FY2025 annual result came in at $233.5 million, down 73.95% from the prior year.
- Long-Term Debt Issuances eased to $13.5 million in Q1 2026, from $233.5 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $895.4 million in Q4 2024 to a low of -$897.5 million in Q2 2024.
- A 5-year average of $27.7 million and a median of $25.0 million in 2022 frame the typical range for Long-Term Debt Issuances.
- The widest YoY moves for Long-Term Debt Issuances: up 2539.4% in 2024, down 2808.21% in 2024.
- Tracing ALVO's Long-Term Debt Issuances over 5 years: stood at -$14.2 million in 2022, then soared by 338.66% to $33.9 million in 2023, then jumped by 2539.4% to $895.4 million in 2024, then plunged by 73.92% to $233.5 million in 2025, then sank by 94.22% to $13.5 million in 2026.
- The last three Long-Term Debt Issuances figures came in at $13.5 million (Q1 2026), $233.5 million (Q4 2025), and -$11.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alvotech | 1.23 Bn | 1.23 Bn | 5.09 Mn | 13.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.50 Mn |
| Mar 31, 2026 | 13.50 Mn |
| Dec 31, 2025 | 233.47 Mn |
| Dec 31, 2025 | 233.47 Mn |
| Sep 30, 2025 | -11.25 Mn |
| Sep 30, 2025 | -11.25 Mn |
| Dec 31, 2024 | 895.36 Mn |
| Dec 31, 2024 | 895.36 Mn |
| Sep 30, 2024 | -66.60 Mn |
| Sep 30, 2024 | -66.60 Mn |
| Jun 30, 2024 | -897.50 Mn |
| Jun 30, 2024 | -897.50 Mn |
| Dec 31, 2023 | 33.92 Mn |
| Dec 31, 2023 | 33.92 Mn |
| Jun 30, 2023 | 33.14 Mn |
| Jun 30, 2023 | 33.14 Mn |
| Mar 31, 2023 | 60.42 Mn |
| Mar 31, 2023 | 60.42 Mn |
| Jun 30, 2022 | -14.21 Mn |
| Jun 30, 2022 | -14.21 Mn |